Haddad, Gaëlle <br/><br/>
PARP inhibitors: a tsunami of indications in different malignancies.  [electronic resource] 

 -  Pharmacogenomics  02 2020 
 - 221-230 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8042 
<br/><br/><label>Standard No.: </label>10.2217/pgs-2019-0113  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Clinical Trials as Topic<br/>DNA Repair--drug effects<br/>Drug Approval<br/>Humans<br/>Mutation<br/>Neoplasms--drug therapy<br/>Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage<br/>Precision Medicine--methods<br/>Survival Analysis